TGFB1 and lung carcinoma: By tackling TGF‐β's role in epithelial–mesenchymal transition (EMT) and immune evasion, this approach opens new avenues for more effective lung cancer therapies and improved patient outcomes, offering hope for a brighter future in lung cancer treatment and patient care.